The Adenomyosis and infertility - underestimated challenge in reproductive medicine

In: Quality in Sport · 2025 · vol. 42 , pp. 60935 · doi:10.12775/qs.2025.42.60935 · W4411654209
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-06

This review summarizes current knowledge on adenomyosis, detailing its pathophysiological mechanisms, diagnostic tools, and classification systems in relation to female infertility and impaired reproductive outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-06 · read from full text

This paper is a narrative literature review that synthesizes evidence on how adenomyosis affects fertility, focusing on proposed pathophysiological mechanisms, diagnostic approaches, and classification systems, using selected PubMed articles indexed by keywords such as “adenomyosis” and “infertility.” It describes adenomyosis as underdiagnosed and characterized by endometrial glands and stroma within the myometrium, leading to progressive structural and functional uterine changes that may impair endometrial receptivity, contribute to implantation failure, and disrupt early pregnancy development. The review concludes that adenomyosis is increasingly recognized as a potential contributor to infertility and argues that it should be considered within the diagnostic work-up and management of infertile patients, while noting that deeper mechanistic understanding is needed. This paper is centrally about adenomyosis—summarizing its effects on infertility and reproductive outcomes.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Introduction: Adenomyosis is considered as a chronic gynecological condition increasingly observed among women of reproductive age. It remains underdiagnosed and frequently underestimated as a contributing factor in fertility disorders. Characterized by the presence of endometrial glands and stroma within the myometrium, adenomyosis causes progressive structural and functional uterine changes that may impair endometrial receptivity and disrupt implantation. Aim of the study: This review aims to summarize current knowledge on the effects of adenomyosis on fertility. It focuses on the pathophysiological mechanisms involved, diagnostic tools, classification systems.. It explores the pathophysiological mechanisms that contribute to impaired reproductive outcomes, as well as available diagnostic methods that enable an effective identification of the condition. Materials and methodology:The literature review includes articles from databases (PubMed), selected to their citation, using keywords “adenomyosis”, “infertility” Conclusion: Adenomyosis is increasingly recognized as a potential contributing factor to female infertility. Anatomical and functional alterations within the uterus may impair embryo implantation and early pregnancy development. Current evidence highlights the importance of including adenomyosis in the diagnostic work-up and management of infertile patients. A deeper understanding of its underlying mechanisms may lead to more effective and individualized treatment strategies.
Full text 9,348 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Introduction

Adenomyosis is considered as a chronic gynecological condition increasingly observed among women of reproductive age. It remains underdiagnosed and frequently underestimated as a contributing factor in fertility disorders. Characterized by the presence of endometrial glands and stroma within the myometrium, adenomyosis causes progressive structural and functional uterine changes that may impair endometrial receptivity and disrupt implantation. Aim of the study: This review aims to summarize current knowledge on the effects of adenomyosis on fertility. It focuses on the pathophysiological mechanisms involved, diagnostic tools, classification systems.. It explores the pathophysiological mechanisms that contribute to impaired reproductive outcomes, as well as available diagnostic methods that enable an effective identification of the condition.

Materials

and methodology:The literature review includes articles from databases (PubMed), selected to their citation, using keywords “adenomyosis”, “infertility”

Conclusion

Adenomyosis is increasingly recognized as a potential contributing factor to female infertility. Anatomical and functional alterations within the uterus may impair embryo implantation and early pregnancy development. Current evidence highlights the importance of including adenomyosis in the diagnostic work-up and management of infertile patients. A deeper understanding of its underlying mechanisms may lead to more effective and individualized treatment strategies.

References

1.Bourdon M, Santulli P, Marcellin L, et al. Adenomyosis: An update regarding its diagnosis and clinical features. J Gynecol Obstet Hum Reprod. 2021;50(10):102228. doi:10.1016/j.jogoh.2021.102228 2.Szubert M, Kozirog E, Wilczynski J. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review. Int J Environ Res Public Health. 2022;19(4):2294. Published 2022 Feb 17. doi:10.3390/ijerph19042294 3.Vercellini P, Viganò P, Somigliana E, Daguati R, Abbiati A, Fedele L. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):465-477. doi:10.1016/j.bpobgyn.2006.01.017 4.Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update. 2020;26(3):392-411. doi:10.1093/humupd/dmz049 5.Szubert M, Koziróg E, Olszak O, Krygier-Kurz K, Kazmierczak J, Wilczynski J. Adenomyosis and Infertility-Review of Medical and Surgical Approaches. Int J Environ Res Public Health. 2021;18(3):1235. Published 2021 Jan 30. doi:10.3390/ijerph18031235 6.Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592-601. doi:10.1016/j.rbmo.2017.06.016 7.Dai Y, Yuan Z, Fan W, Lin Z. Molecular mechanism of aberrant decidualization in adenomyosis leading to reduced endometrial receptivity. Front Endocrinol (Lausanne). 2025;15:1435177. Published 2025 Jan 16. doi:10.3389/fendo.2024.1435177 8.Bulun SE, Yildiz S, Adli M, Wei JJ. Adenomyosis pathogenesis: insights from next-generation sequencing. Hum Reprod Update. 2021;27(6):1086-1097. doi:10.1093/humupd/dmab017 9.Donnez J, Stratopoulou CA, Dolmans MM. Endometriosis and adenomyosis: Similarities and differences. Best Pract Res Clin Obstet Gynaecol. 2024;92:102432. doi:10.1016/j.bpobgyn.2023.102432 10.Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the uterus--revisited. Am J Obstet Gynecol. 1972;112(5):583-593. doi:10.1016/0002-9378(72)90781-8 11.Kishi Y, Suginami H, Kuramori R, Yabuta M, Suginami R, Taniguchi F. Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification. Am J Obstet Gynecol. 2012;207(2):114.e1-114.e1147. doi:10.1016/j.ajog.2012.06.027 12.Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101(2):472-487. doi:10.1016/j.fertnstert.2013.10.025 13.Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril. 2018;109(3):380-388.e1. doi:10.1016/j.fertnstert.2018.01.006 14.Munro MG. Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity. Fertil Steril. 2019;111(4):629-640. doi:10.1016/j.fertnstert.2019.02.008 15.Vercellini P, Viganò P, Bandini V, Buggio L, Berlanda N, Somigliana E. Association of endometriosis and adenomyosis with pregnancy and infertility. Fertil Steril. 2023;119(5):727-740. doi:10.1016/j.fertnstert.2023.03.018 16.Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril. 2017;108(3):483-490.e3. doi:10.1016/j.fertnstert.2017.06.025 17.Pirtea P, de Ziegler D, Ayoubi JM. Endometrial receptivity in adenomyosis and/or endometriosis. Fertil Steril. 2023;119(5):741-745. doi:10.1016/j.fertnstert.2023.03.004 18.Peric H, Fraser IS. The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):547-555. doi:10.1016/j.bpobgyn.2006.01.006 19.Wouk N, Helton M. Abnormal Uterine Bleeding in Premenopausal Women. Am Fam Physician. 2019;99(7):435-443. 20.Kitaya K, Takeuchi T, Mizuta S, Matsubayashi H, Ishikawa T. Endometritis: new time, new concepts. Fertil Steril. 2018;110(3):344-350. doi:10.1016/j.fertnstert.2018.04.012 21.Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies. Expert Opin Pharmacother. 2008;9(15):2661-2672. doi:10.1517/14656566.9.15.2661 22.Harmsen MJ, Trommelen LM, de Leeuw RA, et al. Uterine junctional zone and adenomyosis: comparison of MRI, transvaginal ultrasound and histology. Ultrasound Obstet Gynecol. 2023;62(1):42-60. doi:10.1002/uog.26117 23.Di Spiezio Sardo A, Calagna G, Santangelo F, et al. The Role of Hysteroscopy in the Diagnosis and Treatment of Adenomyosis. Biomed Res Int. 2017;2017:2518396. doi:10.1155/2017/2518396 24.Nirgianakis K, Kalaitzopoulos DR, Schwartz ASK, et al. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis. Reprod Biomed Online. 2021;42(1):185-206. doi:10.1016/j.rbmo.2020.09.023 25.Etrusco A, Barra F, Chiantera V, et al. Current Medical Therapy for Adenomyosis: From Bench to Bedside. Drugs. 2023;83(17):1595-1611. doi:10.1007/s40265-023-01957-7 26.Latif S, Kastora S, Al Wattar BH, Yasmin E, Saridogan E, Mavrelos D. The effectiveness of prolonged downregulation with gonadotrophin-releasing hormone analogue (GnRHa) treatment in women with adenomyosis undergoing IVF/ICSI: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2024;301:87-94. doi:10.1016/j.ejogrb.2024.07.063 27.Moldassarina RS. Modern view on the diagnostics and treatment of adenomyosis. Arch Gynecol Obstet. 2023;308(1):171-181. doi:10.1007/s00404-023-06982-1 28.Donnez J, Stratopoulou CA, Dolmans MM. Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists. Int J Environ Res Public Health. 2021;18(19):9941. Published 2021 Sep 22. doi:10.3390/ijerph18199941 29.Capezzuoli T, Toscano F, Ceccaroni M, et al. Conservative surgical treatment for adenomyosis: New options for looking beyond uterus removal. Best Pract Res Clin Obstet Gynaecol. 2024;95:102507. doi:10.1016/j.bpobgyn.2024.102507 30.Alkatout I, Mazidimoradi A, Günther V, Salehiniya H, Allahqoli L. Total or Subtotal Hysterectomy for the Treatment of Endometriosis: A Review. J Clin Med. 2023;12(11):3697. Published 2023 May 26. doi:10.3390/jcm12113697 31.Osada H. Uterine adenomyosis and adenomyoma: the surgical approach. Fertil Steril. 2018;109(3):406-417. doi:10.1016/j.fertnstert.2018.01.032 32.Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand. 2017;96(6):715-726. doi:10.1111/aogs.13158 33.Jiang L, Han Y, Song Z, Li Y. Pregnancy Outcomes after Uterus-sparing Operative Treatment for Adenomyosis: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2023;30(7):543-554. doi:10.1016/j.jmig.2023.03.015 34.Dedes I, Kolovos G, Fruscalzo A, et al. Radiofrequency Ablation for Adenomyosis. J Clin Med. 2023;12(9):3069. Published 2023 Apr 23. doi:10.3390/jcm12093069 35.Zhang L, Rao F, Setzen R. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility. Acta Obstet Gynecol Scand. 2017;96(6):707-714. doi:10.1111/aogs.13159 36.Liu L, Wang T, Lei B. Image-guided thermal ablation in the management of symptomatic adenomyosis: a systematic review and meta-analysis. Int J Hyperthermia. 2021;38(1):948-962. doi:10.1080/02656736.2021.1939443 Downloads Published How to Cite Issue Section License Copyright (c) 2025 Katarzyna Znamirowska, Martyna Bukała, Karolina Ochyra, Kornelia Pudło, Jowita Frydrych, Gabriela Prucnal, Karolina Ryba, Klaudia Zacher, Patrycja Walkiewicz, Anna Rakoczy This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Stats Number of views and downloads: 356 Number of citations: 0

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK